Table 3.
Sample | %Cell death |
---|---|
Hirano body/GSK3β(K85A) |
4.20 ± 0.77 |
Hirano body/G272V |
17.90 ± 2.59 |
Hirano body/G272V/GSK3β(K85A) |
10.20 ± 1.35 |
GFP/G272V |
4.75 ± 0.74 |
GFP/G272V/ GSK3β(K85A) |
5.80 ± 0.56 |
GFP/G272V + GFP/ GSK3β(K85A) | 8.95 ± 2.06 |
Expression of GSK3β(K85A) reduced the synergistic cell death observed when both G272V and model Hirano bodies are present, to an additive effect, implying that the phosphorylation state is important.